Live Feeds
● LIVE Updated 1h ago · 25 sources tracked

FDA approves new COVID vaccines

Leading United States medical societies have released joint vaccination recommendations for both COVID-19 and the flu ahead of the fall season. Released on Wednesday, these new guidelines attempt to cut through public confusion stemming from shifting federal policies and provide clear, science-based advice for patients. Meanwhile, updated vaccines are arriving at pharmacies. Medical groups generally advise that most individuals aged six months and older should receive an annual flu shot. This unified stance arrives as health authorities manage the ongoing transition to updated COVID vaccine formulations targeted at recent variants.

RSS Source map (25)

What changed

Leading medical groups banded together on Wednesday to issue new, joint vaccination guidelines for COVID-19 and the flu aimed at easing public confusion.

Live updates

  1. Medical Groups Issue Guidance for Fall COVID and Flu Vaccines

    Leading United States medical societies have released joint vaccination recommendations for both COVID-19 and the flu ahead of the fall season. Released on Wednesday, these new guidelines attempt to cut through public confusion stemming from shifting federal policies and provide clear, science-based advice for patients. Meanwhile, updated vaccines are arriving at pharmacies. Medical groups generally advise that most individuals aged six months and older should receive an annual flu shot. This unified stance arrives as health authorities manage the ongoing transition to updated COVID vaccine formulations targeted at recent variants.

    Why it matters

    The unified guidance from medical societies addresses public uncertainty following changes in federal health policies. As pharmacies receive the fresh supply of autumn shots, clearing up conflicting messaging remains a priority for clinicians urging inoculation alongside the traditional flu season preparations.

    What is confirmed

    • Leading United States medical groups issued joint guidelines for updated COVID-19 and flu vaccinations on Wednesday.
    • Medical groups generally agree that most people ages six months and older should receive a flu vaccine.
    • New flu and COVID vaccines are arriving at pharmacies.

    Still unconfirmed

    • Insurance coverage details for the updated fall COVID-19 vaccines remain uncertain as shots arrive at pharmacies.

    What to watch next

    • Whether insurance providers will fully cover the cost of the updated fall COVID-19 vaccines
    • The extent of public uptake following the joint medical guidance and pharmacy deliveries
    Sources used for this update (6)
    1. www.aol.com — Updated COVID-19 vaccines are coming this fall. Will insurance cover them?
    2. www.baltimoresun.com — Top US doctors offer updated flu and COVID vaccine recommendations, aiming to ease confusion
    3. www.newser.com — Doctors Groups Have COVID, Flu Vaccine Recommendations
    4. www.wgauradio.com — New flu, COVID vaccines are arriving at pharmacies
    5. www.ibtimes.com.au — Top Doctors Issue New Flu And COVID Vaccine Guidance For Fall, Aiming To Cut Through Federal Confusion
    6. justthenews.com — CIA notes show FDA chief-turned-Pfizer board member saw race between herd immunity, COVID vaccine
    confidence 92%

  2. FDA Approves XFG-Targeted COVID-19 Vaccines for 2026-2027 Season

    The FDA approved updated COVID-19 vaccine formulations from Pfizer/BioNTech, Moderna, and Novavax targeting the XFG variant for vulnerable populations. Moderna's approved products include Spikevax and mNEXSPIKE. While these shots aim to protect against evolving strains, the transition has created an availability gap as older vaccines were removed from shelves before the new versions rolled out. This rollout coincides with a slow climb in COVID case numbers, though current trends remain below levels seen in previous years during the return to school.

    Why it matters

    Health officials are preparing for fall 2026 vaccinations as SARS-CoV-2 continues to mutate. The shift to XFG-adapted mRNA versions reflects a broader industry move toward mRNA technology for various diseases. This specific update targets the latest subvariant to maintain efficacy.

    What is confirmed

    • The FDA approved updated 2026-2027 COVID-19 vaccine formulations from Pfizer/BioNTech, Moderna, and Novavax targeting the XFG variant.
    • Moderna received approval for its Spikevax and mNEXSPIKE vaccines.

    Still unconfirmed

    • Health experts warn that Kansas City is not in the clear despite lower case trends.

    What to watch next

    • Distribution timelines for Pfizer/BioNTech and Novavax vaccines
    • Case rate data following the fall 2026 vaccination drive
    Sources used for this update (6)
    1. www.kcur.org — As Kansas City kids go back to school, here's what to know about disease and vaccines
    2. mmajunkie.usatoday.com — We asked the CD2 candidates where they stand on RI issues | Exclusive
    3. www.news-medical.net — New method based on human blood simplifies mRNA drug development
    4. pharmaphorum.com — GSK pushes 'next-generation' mRNA flu shot into phase 3
    5. www.endocrinologyadvisor.com — FDA Approves Updated 2026-2027 COVID-19 Vaccines
    6. www.wyff4.com — New COVID-19 vaccine rolls out after FDA approval prompts availability gap
    confidence 90%

  3. FDA approves updated COVID-19 vaccines for 2026-2027 season

    The FDA has approved updated COVID-19 vaccines for the 2026-2027 season, including an XFG-adapted mRNA version. Moderna received approval for its Spikevax and mNEXSPIKE vaccines, which are tailored to the latest SARS-CoV-2 subvariant. These approvals come as cases are rising and the public prepares for fall 2026 vaccinations. The updated shots aim to provide better protection against evolving strains of the virus.

    Why it matters

    Annual vaccine updates are necessary because the SARS-CoV-2 virus continues to mutate into new subvariants. These approvals ensure that the available boosters match the circulating strains for the upcoming respiratory season.

    What is confirmed

    • The FDA approved updated COVID-19 vaccines for the 2026-2027 season.
    • The FDA approved an XFG-adapted mRNA COVID-19 vaccine.
    • Moderna received FDA approval for updated Spikevax and mNEXSPIKE vaccines tailored to the latest SARS-CoV-2 subvariant.

    What to watch next

    • Public distribution dates for the XFG-adapted vaccines
    • FDA clearance status for Moderna's mFlusiva
    • Data on vaccine efficacy against the latest subvariant
    Sources used for this update (15)
    1. The New York Times — What to Know About New Covid Vaccines for Fall 2026
    2. The Washington Post — FDA just approved updated covid shots. Here’s what to know as cases rise.
    3. Pharmacy Times — FDA Approves XFG-Adapted COVID-19 Vaccine, mRNA for the 2026-2027 Season
    4. ABC News - Breaking News, Latest News and Videos — FDA approves updated COVID vaccines. Here's what you need to know
    5. CIDRAP — FDA approves new COVID vaccines
    6. kare11.com — What to know about the COVID and flu vaccines for 2026
    7. finance.yahoo.com — What Do Moderna (MRNA) FDA Vaccine Approvals Mean For Its Respiratory Push?
    8. jen.jiji.com — US Open, today Djokovic-Navone: schedule, head-to-head, and where to watch it on TV
    9. www.aol.com — More And More People Suffer From 'Chemophobia' — And MAHA Is Partly To Blame
    10. www.devdiscourse.com — Can Africa’s New Strategy Make Medicines Safer and Strengthen Local Drug Production?
    11. abcnews.com — NASA's newest space telescope launches on a quest to explore the hidden universe
    12. finance.yahoo.com — Merck (MRK) Posts First Positive Phase 3 Result For Personalized mRNA Melanoma Therapy
    confidence 100%